- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 13, 2026 | 4.98M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 4.8M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 3.96M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.73M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.34M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $9.53M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $13.36M |
| Cash And Equivalents | Q1 2026 · Sep 30, 2025 | $9.5M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$12.69M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$14.23M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$21.79M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$19.59M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $7.29M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $13.03M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $10.02M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $13.85M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $10.38M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $14.24M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.57 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.70 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.57 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.70 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.68M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.27M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $1.2M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $1.26M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.74M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.77M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$2.88M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$2.7M |